Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMorgan Sindall Group Regulatory News (MGNS)

Share Price Information for Morgan Sindall Group (MGNS)

Share Price is delayed by 15 minutes
Get Live Data
4,426.00    -4.00 (-0.09%)
Bid:
4,424.00
Ask:
4,428.00
Spread: 4.00 (0.09%)
Market Cap: £2.06b
MGNS Live PriceLast checked at - London Stock Exchange

Intraday Morgan Sindall Group Share Chart

Interim Management Statement

7 Nov 2013 07:00

RNS Number : 3954S
Morgan Sindall Group PLC
07 November 2013
Β 

ο»Ώ

Β 

Β 

7 November 2013

Morgan Sindall Group plc

Β 

Q3 Interim Management Statement

Β 

Morgan Sindall Group plc ('the Group') today announces its Interim Management Statement for the period from 1 July 2013 to date.

Β 

Group Performance

Β 

The overall Group performance in the third quarter ('Q3') was in line with the Board's expectations as at the time of the half year results on 5 August 2013 and followed a broadly similar trend to the first half. Within this, Group revenue held up well when compared to Q3 2012, whilst Group margin was impacted primarily by margin contraction in the Construction & Infrastructure division.

Β 

The Group's forward order book as at the end of Q3 was Β£3.3bn, up 6% from the half year position.

Β 

Operating Performance

Β 

In Construction & Infrastructure, there has been no significant change in market conditions or performance in Q3. The focus for the division remains on operational delivery, contract selectivity through the risk management of contractual terms & conditions and working capital management. As markets recover, upward pressure on material costs and subcontractor costs will provide additional management challenges.

Β 

Fit Out has seen no significant change to performance or order book in Q3 compared to the first half, however there are early indications of increasing confidence of market improvement through 2014 and beyond.

Β 

As expected, performance in Affordable Housing has improved in Q3 over the first half. This has been driven primarily by continued positive trends in its open market housing activities, with an increase in open market house sale completions of 41% in the nine months of 2013, compared to the same period in 2012. However, there remains significant competitive pressure on construction revenue and margins, exacerbated by increasing material costs and subcontractor costs.

Β 

The level of activity on Urban Regeneration projects continues to provide confidence that the division is well-placed to benefit from 2014 onwards. Since the half year, the division was appointed by South Tyneside Council as the sole developer of the Β£100m South Shields 365 town centre renewal.

Β 

Investments continued with its strategy of recycling its invested capital, with the sale of its interest in Tayside Health Holdings Limited during the period, at a value in line with expected returns from this division.

Β 

Financial Position

Net debt as at 31 October 2013 was Β£15m. The average daily net debt from the start of the year up to 31 October was Β£23m, a continued improvement from the half year average of Β£32m. Q3 average daily net debt was Β£13m.

Outlook

Based upon current progress across all its activities, the Group is on course to deliver a result for the year in line with the Board's expectations. Looking further ahead, the Board remains confident that the business is well-positioned to benefit from profitable opportunities as its markets recover.

Β 

ENDS

Morgan Sindall Group

Morgan Sindall Group plc is a leading UK construction and regeneration group with revenue of cΒ£2 billion, employing around 6,500 employees and operating in the public and commercial sectors. It operates through five divisions of construction and infrastructure, fit out, affordable housing, urban regeneration and investments.

Β 

ENQUIRIES:

Β 

Morgan Sindall Group Tel: 020 7307 9200

John Morgan, Chief Executive

Steve Crummett, Finance Director

Β 

Brunswick Tel: 020 7404 5959

Jonathan Glass

Nina Coad

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBLBDBCXGBGXL
Date   Source Headline
21st Aug 20204:15 pmRNSHolding(s) in Company
6th Aug 202012:25 pmRNSHolding(s) in Company
5th Aug 20207:00 amRNSHalf-year Report
3rd Aug 20209:54 amRNSTotal Voting Rights
27th Jul 20207:00 amRNSForward funding secured for £185m New Victoria
14th Jul 20208:30 amRNS£252m forward funding deal of Lewisham Gateway
7th Jul 20203:21 pmRNSHolding(s) in Company
6th Jul 20207:00 amRNSNotice of Results
1st Jul 20202:49 pmRNSHolding(s) in Company
1st Jul 20208:50 amRNSTotal Voting Rights
25th Jun 20203:29 pmRNSHolding(s) in Company
22nd Jun 202011:27 amRNSDirector Declaration
18th Jun 20202:02 pmRNSHolding(s) in Company
10th Jun 202012:02 pmRNSPrice Monitoring Extension
1st Jun 202011:48 amRNSTotal Voting Rights
28th May 20202:52 pmRNSDirector/PDMR Shareholding
13th May 20209:00 amRNSAdditional Listing
7th May 20201:30 pmRNSResult of AGM
7th May 20207:00 amRNSAGM Trading Update
1st May 202010:54 amRNSTotal Voting Rights
1st May 202010:37 amRNSChange in Director's details
27th Apr 202010:40 amRNSDisclosure of rights attached to equity shares
20th Apr 20201:10 pmRNSBlock listing Interim Review
2nd Apr 20202:57 pmRNSAnnual Financial Report
1st Apr 202012:08 pmRNSTotal Voting Rights
25th Mar 20207:00 amRNSCOVID-19 Update
11th Mar 20203:45 pmRNSHolding(s) in Company
11th Mar 20208:30 amRNSAdditional Listing
9th Mar 20202:33 pmRNSHolding(s) in Company
9th Mar 20202:13 pmRNSDirector/PDMR Shareholding
3rd Mar 20202:14 pmRNSHolding(s) in Company
2nd Mar 20204:15 pmRNSDirector/PDMR Shareholding
2nd Mar 20204:08 pmRNSDirector/PDMR Shareholding
2nd Mar 20203:19 pmRNSTotal Voting Rights
27th Feb 20202:02 pmRNSHolding(s) in Company
27th Feb 20201:48 pmRNSHolding(s) in Company
27th Feb 20201:39 pmRNSHolding(s) in Company
27th Feb 202010:35 amRNSDirector/PDMR Shareholding
24th Feb 20205:45 pmRNSSophos Group
20th Feb 20207:00 amRNSFinal Results
3rd Feb 20204:20 pmRNSTotal Voting Rights
31st Jan 20203:44 pmRNSHolding(s) in Company
29th Jan 20204:18 pmRNSHolding(s) in Company
24th Jan 20203:25 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSDirectorate Change
9th Jan 20207:00 amRNSNotice of Results
7th Jan 20204:39 pmRNSHolding(s) in Company
2nd Jan 20208:30 amRNSTotal Voting Rights
21st Nov 20199:21 amRNSDirector/PDMR Shareholding
20th Nov 201911:43 amRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.